Top Markets
Coin of the day
Theraclion SA Theraclion SA

Theraclion SA

ALTHE
Rank in Stocks #15409
Theraclion SA develops echotherapy solutions using high intensity focused... Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Share Price
$0.78404857
Market Cap
$36.98M
Change (1 day)
-1.49%
Change (1 year)
139.26%
Country
FR
Trade Theraclion SA (ALTHE)

Category

Number of shares outstanding for Theraclion SA (ALTHE)
Number of shares outstanding as of December 2025: 58.16M
According to Theraclion SA latest financial reports and stock price the company's current number of shares outstanding is 58.16M. At the end of December 2023 the company had 45.73M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Theraclion SA (ALTHE) from 2010 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 58.16M 26.17%
2024 46.09M 0.79%
2023 45.73M 55.62%
2022 29.39M 29.07%
2021 22.77M 40.73%
2020 16.18M 6.12%
2019 15.25M 80.65%
2018 8.44M 12.94%
2017 7.47M 16.02%
2016 6.44M 58.50%
2015 4.06M 16.03%
2014 3.50M 22.72%
2013 2.85M -4.63%
2012 2.99M 0.00%
2011 2.99M 0.00%
2010 2.99M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
1.75B 2,903.97%
US
382.90M 558.41%
US
1.28B 2,103.59%
IE
1.48B 2,453.35%
US
579.20M 895.96%
US